Abstract
Colorectal cancer (CRC) is one of the most frequently diagnosed cancers and, despite improved colonoscopic screening, CRC is a leading cause of death from cancer. Administration of bovine lactoferrin (bLF) suppresses carcinogenesis in the colon and other organs of test animals, and recently it was shown that ingestion of bLF inhibits the growth of adenomatous polyps in human patients. Here we review work which established bLF as an anti-carcinogenic agent in laboratory animals and the results of a clinical trial which demonstrated that bLF can reduce the risk of colon carcinogenesis in humans.
Similar content being viewed by others
References
Bezault J, Bhimani R, Wiprovnick J et al (1994) Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 54:2310–2312
Cao R, Farnebo J, Kurimoto M et al (1999) Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB J 13:2195–2202
Chawla-Sarkar M, Lindner DJ, Liu YF et al (2003) Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8:237–249
Clemens MJ (2003) Interferons and apoptosis. J Interferon Cytokine Res 23:277–292
Cramer E, Pryzwansky KB, Villeval JL et al (1985) Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold. Blood 65:423–432
de la Rosa G, Yang D, Tewary P et al (2008) Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J Immunol 180:6868–6876
Freiburghaus C, Janicke B, Lindmark-Mansson H et al (2009) Lactoferricin treatment decreases the rate of cell proliferation of a human colon cancer cell line. J Dairy Sci 92:2477–2484
Fujita K, Matsuda E, Sekine K et al (2004a) Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats. Carcinogenesis 25:1961–1966
Fujita K, Matsuda E, Sekine K et al (2004b) Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat. Cancer Lett 213:21–29
Gahr M, Speer CP, Damerau B et al (1991) Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J Leukoc Biol 49:427–433
Hessle C, Hanson LA, Wold AE (1999) Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol 116:276–282
Hofstad B, Vatn MH, Andersen SN et al (1996) Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. Gut 39:449–456
Hwang SA, Wilk KM, Bangale YA et al (2007) Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes. Med Microbiol Immunol 196:171–180
Iigo M, Kuhara T, Ushida Y et al (1999) Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis 17:35–40
Iigo M, Shimamura M, Matsuda E et al (2004) Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis. Cytokine 25:36–44
Iigo M, Shimamura M, Hirano S et al (2005) Cancer prevention and anti-metastatic effects by oral administration of bovine lactoferrin. In: Takuji T, Hiroyuki T (eds) Carcinogenesis and modification of carcinogenesis. Research Signpost, Kerala, India, pp 229–242
Iigo M, Alexander DB, Long N et al (2009) Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine. Biochimie 91:86–101
Kozu T, Iinuma G, Ohashi Y et al (2009) Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prev Res (Phila Pa) 2:975–983
Kudo S, Tamura S, Nakajima T et al (1996) Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 44:8–14
Kudo S, Rubio CA, Teixeira CR et al (2001) Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy 33:367–373
Kuhara T, Iigo M, Itoh T et al (2000) Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutr Cancer 38:192–199
Kuhara T, Yamauchi K, Tamura Y et al (2006) Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine. J Interferon Cytokine Res 26:489–499
Legrand D, Pierce A, Elass E et al (2008) Lactoferrin structure and functions. Adv Exp Med Biol 606:163–194
Levay PF, Viljoen M (1995) Lactoferrin: a general review. Haematologica 80:252–267
Levin B, Lieberman DA, McFarland B et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58:130–160
Lonnerdal B, Iyer S (1995) Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15:93–110
Masuda C, Wanibuchi H, Sekine K et al (2000) Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis. Jpn J Cancer Res 91:582–588
McCarty MF, Bielenberg D, Donawho C et al (2002) Evidence for the causal role of endogenous interferon-alpha/beta in the regulation of angiogenesis, tumorigenicity, and metastasis of cutaneous neoplasms. Clin Exp Metastasis 19:609–615
McCormick JA, Markey GM, Morris TC et al (1991) Lactoferrin inducible monocyte cytotoxicity defective in esterase deficient monocytes. Br J Haematol 77:287–290
McIntosh GH, Regester GO, Le Leu RK et al (1995) Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J Nutr 125:809–816
Nishiya K, Horwitz DA (1982) Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity. J Immunol 129:2519–2523
Norrby K, Mattsby-Baltzer I, Innocenti M et al (2001) Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat. Int J Cancer 91:236–240
Queen MM, Ryan RE, Holzer RG et al (2005) Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res 65:8896–8904
Rehman MU, Buttar QM, Khawaja MI et al (2009) An impending cancer crisis in developing countries: are we ready for the challenge? Asian Pac J Cancer Prev 10:719–720
Sekine K, Watanabe E, Nakamura J et al (1997) Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn J Cancer Res 88:523–526
Shau H, Kim A, Golub SH (1992) Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J Leukoc Biol 51:343–349
Shimamura M, Yamamoto Y, Ashino H et al (2004) Bovine lactoferrin inhibits tumor-induced angiogenesis. Int J Cancer 111:111–116
Sidky YA, Borden EC (1987) Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 47:5155–5161
Spadaro M, Curcio C, Varadhachary A et al (2007) Requirement for IFN-gamma, CD8+ T lymphocytes, and NKT cells in talactoferrin-induced inhibition of neu+ tumors. Cancer Res 67:6425–6432
Spadaro M, Caorsi C, Ceruti P et al (2008) Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. FASEB J 22:2747–2757
Su MY, Ho YP, Chen PC et al (2004) Magnifying endoscopy with indigo carmine contrast for differential diagnosis of neoplastic and nonneoplastic colonic polyps. Dig Dis Sci 49:1123–1127
Takeuchi M, Nishizaki Y, Sano O et al (1997) Immunohistochemical and immuno-electron-microscopic detection of interferon-gamma-inducing factor (“interleukin-18”) in mouse intestinal epithelial cells. Cell Tissue Res 289:499–503
Tamano S, Sekine K, Takase M et al (2008) Lack of chronic oral toxicity of chemopreventive bovine lactoferrin in F344/DuCrj rats. Asian Pac J Cancer Prev 9:313–316
Tanaka T, Kawabata K, Kohno H et al (2000) Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. Jpn J Cancer Res 91:25–33
Togashi K, Konishi F, Ishizuka T et al (1999) Efficacy of magnifying endoscopy in the differential diagnosis of neoplastic and non-neoplastic polyps of the large bowel. Dis Colon Rectum 42:1602–1608
Tsuda H, Sekine K (2000) Milk components as cancer chemopreventive agents. Asian Pac J Cancer Prev 1:277–282
Tsuda H, Sekine K, Nakamura J et al (1998) Inhibition of azoxymethane initiated colon tumor and aberrant crypt foci development by bovine lactoferrin administration in F344 rats. Adv Exp Med Biol 443:273–284
Tsuda H, Sekine K, Uehara N et al (1999) Heterocyclic amine mixture carcinogenesis and its enhancement by caffeine in F344 rats. Cancer Lett 143:229–234
Tsuda H, Sekine K, Fujita K et al (2002) Cancer prevention by bovine lactoferrin and underlying mechanisms—a review of experimental and clinical studies. Biochem Cell Biol 80:131–136
Turesky RJ, Constable A, Fay LB et al (1999) Interspecies differences in metabolism of heterocyclic aromatic amines by rat and human P450 1A2. Cancer Lett 143:109–112
Ushida Y, Sekine K, Kuhara T et al (1998) Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc(Min) mouse. Cancer Lett 134:141–145
Ushida Y, Sekine K, Kuhara T et al (1999) Possible chemopreventive effects of bovine lactoferrin on esophagus and lung carcinogenesis in the rat. Jpn J Cancer Res 90:262–267
van den Tol MP, ten Raa S, van Grevenstein WM et al (2007) The post-surgical inflammatory response provokes enhanced tumour recurrence: a crucial role for neutrophils. Dig Surg 24:388–394
van Rijn JC, Reitsma JB, Stoker J et al (2006) Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 101:343–350
Varadhachary A, Wolf JS, Petrak K et al (2004) Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int J Cancer 111:398–403
von Marschall Z, Scholz A, Cramer T et al (2003) Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. J Natl Cancer Inst 95:437–448
Wada Y, Yoshida K, Tsutani Y et al (2007) Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines. Oncol Rep 17:161–167
Wakabayashi H, Takakura N, Yamauchi K et al (2006) Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin. Clin Vaccine Immunol 13:239–245
Wang WP, Iigo M, Sato J et al (2000) Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn J Cancer Res 91:1022–1027
Weisburger JH (1993) Heterocyclic amines in cooked foods: possible human carcinogens. Cancer Res 53:2422–2424
Wislez M, Antoine M, Rabbe N et al (2007) Neutrophils promote aerogenous spread of lung adenocarcinoma with bronchioloalveolar carcinoma features. Clin Cancer Res 13:3518–3527
Wolf JS, Li D, Taylor RJ et al (2003) Lactoferrin inhibits growth of malignant tumors of the head and neck. ORL J Otorhinolaryngol Relat Spec 65:245–249
Wolf JS, Li G, Varadhachary A et al (2007) Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo. Clin Cancer Res 13:1601–1610
Yang D, de la Rosa G, Tewary P et al (2009) Alarmins link neutrophils and dendritic cells. Trends Immunol 11:531–537
Acknowledgments
We thank Shigeru Nawano, Atsushi Otsu, Tomotaka Sobue, and Chikuma Hamada as members of the Independent Data Monitoring Committee; Takahisa Matsuda, Ryuzo Sekiguichi, and Kunihisa Miyakawa for their valuable contributions to the bLF trial; and finally, Takuji Gotoda at the Endoscopic Data Adjudication Committee, Tadakazu Shimoda, a pathologist, Takahiro Fujii, an endoscopist (until June 2003), and Morinaga Milk Industry Ltd., the bLF trial sponsor. We thank Morinaga Milk Industry for providing the bovine lactoferrin and placebo tablets.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsuda, H., Kozu, T., Iinuma, G. et al. Cancer prevention by bovine lactoferrin: from animal studies to human trial. Biometals 23, 399–409 (2010). https://doi.org/10.1007/s10534-010-9331-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10534-010-9331-3